Newcastle University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Newcastle University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014004
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Newcastle University (NU) is an educational university that offers teaching and research services. The university provides teaching and study services including postgraduate study, undergraduate study, and campus services. It offers teaching services in areas of accounting and finance; agri-business management, agriculture, ancient history, animal science, archaeology, biology and zoology. NU also provides services in business management, chemical engineering, civil engineering, classics and ancient history; computing science, history, journalism, law and others. The university offers research programs in humanities and social sciences; medical sciences, science, agriculture and engineering areas. It also provides accommodation to its students. The university has its operations in Malaysia, Singapore and the UK. NU is headquartered in Newcastle Upon Tyne, the UK.

Newcastle University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Newcastle University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Newcastle University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Newcastle University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Newcastle University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Newcastle University, Medical Devices Deals, 2011 to YTD 2017 9
Newcastle University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Newcastle University, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
QuantuMDx Raises USD8.4 Million in Venture Financing 11
Partnerships 12
DNA2.0 Enters Into Research Agreement With Newcastle University For Bacillus subtillis Expression System 12
Astex Pharma, Cancer Research Technology And Newcastle University Enter Into Drug Discovery Agreement 13
MdxHealth Enters Into Co-Development Agreement With Newcastle University, Cancer Research Technology And Pfizer 15
Licensing Agreements 17
Epistem Holdings and CRT Enter into Licensing Agreement with Newcastle University 17
Newcells Biotech Receives IP Technology Rights from Newcastle University 18
Newcastle University – Key Competitors 19
Newcastle University – Key Employees 20
Newcastle University – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Government and Public Interest 22
Sep 14, 2017: Newcastle researchers awarded £1.7million to investigate heart attack treatments for patients over 75 22
Jul 20, 2017: £2 Million NIHR Award for Newcastle University to Focus on Dementia Care and Prevention on a Global Scale 24
Jun 08, 2016: New safety and efficacy evidence for mitochondrial donation revealed 25
May 19, 2016: New SHIELD to tackle antibiotic resistance 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Newcastle University, Pharmaceuticals & Healthcare, Key Facts 2
Newcastle University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Newcastle University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Newcastle University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Newcastle University, Deals By Therapy Area, 2011 to YTD 2017 8
Newcastle University, Medical Devices Deals, 2011 to YTD 2017 9
Newcastle University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
QuantuMDx Raises USD8.4 Million in Venture Financing 11
DNA2.0 Enters Into Research Agreement With Newcastle University For Bacillus subtillis Expression System 12
Astex Pharma, Cancer Research Technology And Newcastle University Enter Into Drug Discovery Agreement 13
MdxHealth Enters Into Co-Development Agreement With Newcastle University, Cancer Research Technology And Pfizer 15
Epistem Holdings and CRT Enter into Licensing Agreement with Newcastle University 17
Newcells Biotech Receives IP Technology Rights from Newcastle University 18
Newcastle University, Key Competitors 19
Newcastle University, Key Employees 20
Newcastle University, Subsidiaries 21

★海外企業調査レポート[Newcastle University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nisshin Seifun Group Inc:戦略・SWOT・企業財務分析
    Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report Summary Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ATCO Power Ltd:企業の戦略的SWOT分析
    ATCO Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Sensorion SA (ALSEN):企業の財務・戦略的SWOT分析
    Summary Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, …
  • World Fuel Services Corp (INT):企業の財務・戦略的SWOT分析
    World Fuel Services Corp (INT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • AyoxxA Biosystems GmbH:医療機器:M&Aディール及び事業提携情報
    Summary AyoxxA Biosystems GmbH (AyoxxA) is a life science tools company that provides protein analysis solutions. The company offers multiple detection kits, cytokine detection kits, human inflammation kits, mouse inflammation kits, and human opthalmology kits. Its services include complete testing …
  • Sun Hung Kai Properties Limited:戦略・SWOT・企業財務分析
    Sun Hung Kai Properties Limited - Strategy, SWOT and Corporate Finance Report Summary Sun Hung Kai Properties Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Jordan Ahli Bank PSC:企業の戦略・SWOT・財務分析
    Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report Summary Jordan Ahli Bank PSC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ora Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ora Inc (Ora) is an ophthalmic contract research organization that provides clinical research and drug development services. The organization offers pre-clinical research, animal toxicology studies, and compounds identification and procurement services. It offers clinical study project manag …
  • Amicus Therapeutics Inc (FOLD):製薬・医療:M&Aディール及び事業提携情報
    Summary Amicus Therapeutics Inc (Amicus Therapeutics) is a biotechnology company that focuses on the research, development and commercialization of small molecules drugs and orally administered drugs known as pharmacological chaperones for the treatment of rare and orphan diseases. The company's lea …
  • Alpha Petroleum Resources Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Alpha Petroleum Resources Ltd (Alpha Petroleum), formerly ATP Oil & Gas (UK) Ltd, a subsidiary of Alpha Petroleum (UK) Holdings Ltd, is an upstream oil and gas company that offers operation, development and production activities in the UK sector of the North Sea. The company operates product …
  • Fairfax Financial Holdings Limited:企業のM&A・事業提携・投資動向
    Fairfax Financial Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fairfax Financial Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Phoenix Global Resources Plc (PGR):企業の財務・戦略的SWOT分析
    Phoenix Global Resources Plc (PGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • KCC Corp (002380):企業の財務・戦略的SWOT分析
    KCC Corp (002380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Synchronoss Technologies, Inc. (SNCR):企業の戦略的SWOT分析
    Synchronoss Technologies, Inc. (SNCR) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • T2 Biosystems Inc (TTOO):製薬・医療:M&Aディール及び事業提携情報
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • BASF Corp-エネルギー分野:企業M&A・提携分析
    Summary BASF Corp (BASF), a subsidiary of BASF SE, is a chemical manufacturing company. Its product portfolio includes petrochemicals, monomers, intermediates, dispersions and pigments, care chemicals, nutrition and health products, paper chemicals, performance chemicals, catalysts, construction che …
  • Par Pacific Holdings, Inc. (PARR):企業の財務・戦略的SWOT分析
    Par Pacific Holdings, Inc. (PARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Telekom Austria AG:企業の戦略・SWOT・財務情報
    Telekom Austria AG - Strategy, SWOT and Corporate Finance Report Summary Telekom Austria AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Schaffer Corporation Limited (SFC):企業の財務・戦略的SWOT分析
    Schaffer Corporation Limited (SFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • IMEXHS Ltd (IME):企業の財務・戦略的SWOT分析
    IMEXHS Ltd (IME) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆